Genetic Technologies Limited Provides End of Year Update on the Test Development Program
MELBOURNE, Australia, Dec. 21, 2018 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), a diversified molecular diagnostics company embracing […]